The burden of Progressive Fibrotic Interstitial lung disease across the UK

Thomas Simpson; Shaney L Barratt; Paul Beirne; Nazia Chaudhuri; Anjali Crawshaw; Louise E Crowley; Sophie Fletcher; Michael A Gibbons; Philippa Hallchurch; Laura Horgan; Ieva Jakaityte; Thomas Lewis; Tom McLellan; Katherine J Myall; Ryan Miller; David J F Smith; Stefan Stanel; Muhunthan Thillai; Fiona Thompson; Timothy Wallis; Zhe Wu; Philip L Molyneaux; Alex G West

doi:10.1183/13993003.00221-2021

The burden of Progressive Fibrotic Interstitial lung disease across the UK

Thomas Simpson, Shaney L Barratt, Paul Beirne, Nazia Chaudhuri, Anjali Crawshaw, Louise E Crowley, Sophie Fletcher, Michael A Gibbons, Philippa Hallchurch, Laura Horgan, Ieva Jakaityte, Thomas Lewis, Tom McLellan, Katherine J Myall, Ryan Miller, David J F Smith, Stefan Stanel, Muhunthan Thillai, Fiona Thompson, Timothy WallisZhe Wu, Philip L Molyneaux^*, Alex G West

^*Corresponding author for this work

Research output: Contribution to journal › Letter (Academic Journal) › peer-review

48 Citations (Scopus)

66 Downloads (Pure)

Abstract

[No abstract]

Original language	English
Article number	2100221
Number of pages	4
Journal	The European respiratory journal
Volume	58
Issue number	1
Early online date	7 Mar 2021
DOIs	https://doi.org/10.1183/13993003.00221-2021
Publication status	Published - 8 Jul 2021

Bibliographical note

Funding Information:
Conflict of interest: T. Simpson reports non-financial support (educational support/leadership course) from Boehringer Ingelheim, outside the submitted work. S.L. Barratt reports grants, personal fees and non-financial support for meeting attendance from Boehringer Ingelheim, outside the submitted work. P. Beirne reports personal fees for consultancy and non-financial support for meeting attendance from Boehringer Ingelheim Pharmaceuticals, outside the submitted work. N. Chaudhuri reports grants and personal fees for consultancy from Boehringer Ingelheim, personal fees for consultancy from Roche, outside the submitted work. A. Crawshaw has received honoraria from Boehringer Ingelheim for educational meetings (chair/talks) and grants for virtual attendance at international conferences. L.E. Crowley has nothing to disclose. S. Fletcher has nothing to disclose. M.A. Gibbons has served on advisory boards and received support to attend conferences from Roche and Boehringer Ingelheim. P. Hallchurch has nothing to disclose. L. Horgan has nothing to disclose. I. Jakaityte has nothing to disclose. T. Lewis has nothing to disclose. T. McLellan reports unrestricted educational grants from Boehringer Ingelheim, outside the submitted work. K.J. Myall has nothing to disclose. R. Miller has nothing to disclose. D.J.F. Smith has nothing to disclose. S. Stanel has nothing to disclose. M. Thillai has nothing to disclose. F. Thompson has nothing to disclose. T. Wallis has nothing to disclose. Z. Wu has nothing to disclose. P.L. Molyneaux, via his institution, received industry–academic funding from AstraZeneca and has received speaker and consultancy fees from Boehringer Ingelheim and Hoffman-La Roche, outside the submitted work. A.G. West has nothing to disclose.

Funding Information:
Support statement: P.L. Molyneaux is supported by an Action for Pulmonary Fibrosis Mike Bray fellowship.

Research Groups and Themes

Academic Respiratory Unit

Access to Document

10.1183/13993003.00221-2021Licence: CC BY

Handle.net

Persistent link

Cite this

Simpson, T., Barratt, S. L., Beirne, P., Chaudhuri, N., Crawshaw, A., Crowley, L. E., Fletcher, S., Gibbons, M. A., Hallchurch, P., Horgan, L., Jakaityte, I., Lewis, T., McLellan, T., Myall, K. J., Miller, R., Smith, D. J. F., Stanel, S., Thillai, M., Thompson, F., ... West, A. G. (2021). The burden of Progressive Fibrotic Interstitial lung disease across the UK. The European respiratory journal, 58(1), Article 2100221. https://doi.org/10.1183/13993003.00221-2021

@article{7899a2ef85d348a29dfed9c6eab56805,

title = "The burden of Progressive Fibrotic Interstitial lung disease across the UK",

abstract = "[No abstract]",

author = "Thomas Simpson and Barratt, {Shaney L} and Paul Beirne and Nazia Chaudhuri and Anjali Crawshaw and Crowley, {Louise E} and Sophie Fletcher and Gibbons, {Michael A} and Philippa Hallchurch and Laura Horgan and Ieva Jakaityte and Thomas Lewis and Tom McLellan and Myall, {Katherine J} and Ryan Miller and Smith, {David J F} and Stefan Stanel and Muhunthan Thillai and Fiona Thompson and Timothy Wallis and Zhe Wu and Molyneaux, {Philip L} and West, {Alex G}",

note = "Funding Information: Conflict of interest: T. Simpson reports non-financial support (educational support/leadership course) from Boehringer Ingelheim, outside the submitted work. S.L. Barratt reports grants, personal fees and non-financial support for meeting attendance from Boehringer Ingelheim, outside the submitted work. P. Beirne reports personal fees for consultancy and non-financial support for meeting attendance from Boehringer Ingelheim Pharmaceuticals, outside the submitted work. N. Chaudhuri reports grants and personal fees for consultancy from Boehringer Ingelheim, personal fees for consultancy from Roche, outside the submitted work. A. Crawshaw has received honoraria from Boehringer Ingelheim for educational meetings (chair/talks) and grants for virtual attendance at international conferences. L.E. Crowley has nothing to disclose. S. Fletcher has nothing to disclose. M.A. Gibbons has served on advisory boards and received support to attend conferences from Roche and Boehringer Ingelheim. P. Hallchurch has nothing to disclose. L. Horgan has nothing to disclose. I. Jakaityte has nothing to disclose. T. Lewis has nothing to disclose. T. McLellan reports unrestricted educational grants from Boehringer Ingelheim, outside the submitted work. K.J. Myall has nothing to disclose. R. Miller has nothing to disclose. D.J.F. Smith has nothing to disclose. S. Stanel has nothing to disclose. M. Thillai has nothing to disclose. F. Thompson has nothing to disclose. T. Wallis has nothing to disclose. Z. Wu has nothing to disclose. P.L. Molyneaux, via his institution, received industry–academic funding from AstraZeneca and has received speaker and consultancy fees from Boehringer Ingelheim and Hoffman-La Roche, outside the submitted work. A.G. West has nothing to disclose. Funding Information: Support statement: P.L. Molyneaux is supported by an Action for Pulmonary Fibrosis Mike Bray fellowship.",

year = "2021",

month = jul,

day = "8",

doi = "10.1183/13993003.00221-2021",

language = "English",

volume = "58",

journal = "The European respiratory journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "1",

}

Simpson, T, Barratt, SL, Beirne, P, Chaudhuri, N, Crawshaw, A, Crowley, LE, Fletcher, S, Gibbons, MA, Hallchurch, P, Horgan, L, Jakaityte, I, Lewis, T, McLellan, T, Myall, KJ, Miller, R, Smith, DJF, Stanel, S, Thillai, M, Thompson, F, Wallis, T, Wu, Z, Molyneaux, PL & West, AG 2021, 'The burden of Progressive Fibrotic Interstitial lung disease across the UK', The European respiratory journal, vol. 58, no. 1, 2100221. https://doi.org/10.1183/13993003.00221-2021

TY - JOUR

T1 - The burden of Progressive Fibrotic Interstitial lung disease across the UK

AU - Simpson, Thomas

AU - Barratt, Shaney L

AU - Beirne, Paul

AU - Chaudhuri, Nazia

AU - Crawshaw, Anjali

AU - Crowley, Louise E

AU - Fletcher, Sophie

AU - Gibbons, Michael A

AU - Hallchurch, Philippa

AU - Horgan, Laura

AU - Jakaityte, Ieva

AU - Lewis, Thomas

AU - McLellan, Tom

AU - Myall, Katherine J

AU - Miller, Ryan

AU - Smith, David J F

AU - Stanel, Stefan

AU - Thillai, Muhunthan

AU - Thompson, Fiona

AU - Wallis, Timothy

AU - Wu, Zhe

AU - Molyneaux, Philip L

AU - West, Alex G

N1 - Funding Information: Conflict of interest: T. Simpson reports non-financial support (educational support/leadership course) from Boehringer Ingelheim, outside the submitted work. S.L. Barratt reports grants, personal fees and non-financial support for meeting attendance from Boehringer Ingelheim, outside the submitted work. P. Beirne reports personal fees for consultancy and non-financial support for meeting attendance from Boehringer Ingelheim Pharmaceuticals, outside the submitted work. N. Chaudhuri reports grants and personal fees for consultancy from Boehringer Ingelheim, personal fees for consultancy from Roche, outside the submitted work. A. Crawshaw has received honoraria from Boehringer Ingelheim for educational meetings (chair/talks) and grants for virtual attendance at international conferences. L.E. Crowley has nothing to disclose. S. Fletcher has nothing to disclose. M.A. Gibbons has served on advisory boards and received support to attend conferences from Roche and Boehringer Ingelheim. P. Hallchurch has nothing to disclose. L. Horgan has nothing to disclose. I. Jakaityte has nothing to disclose. T. Lewis has nothing to disclose. T. McLellan reports unrestricted educational grants from Boehringer Ingelheim, outside the submitted work. K.J. Myall has nothing to disclose. R. Miller has nothing to disclose. D.J.F. Smith has nothing to disclose. S. Stanel has nothing to disclose. M. Thillai has nothing to disclose. F. Thompson has nothing to disclose. T. Wallis has nothing to disclose. Z. Wu has nothing to disclose. P.L. Molyneaux, via his institution, received industry–academic funding from AstraZeneca and has received speaker and consultancy fees from Boehringer Ingelheim and Hoffman-La Roche, outside the submitted work. A.G. West has nothing to disclose. Funding Information: Support statement: P.L. Molyneaux is supported by an Action for Pulmonary Fibrosis Mike Bray fellowship.

PY - 2021/7/8

Y1 - 2021/7/8

N2 - [No abstract]

AB - [No abstract]

UR - https://research-information.bris.ac.uk/en/publications/7899a2ef-85d3-48a2-9dfe-d9c6eab56805

U2 - 10.1183/13993003.00221-2021

DO - 10.1183/13993003.00221-2021

M3 - Letter (Academic Journal)

C2 - 33678609

SN - 0903-1936

VL - 58

JO - The European respiratory journal

JF - The European respiratory journal

IS - 1

M1 - 2100221

ER -

The burden of Progressive Fibrotic Interstitial lung disease across the UK

Abstract

Bibliographical note

Research Groups and Themes

Access to Document

Handle.net

Other files and links

Fingerprint

Cite this